- Record: found
- Abstract: found
- Article: not found
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993.
M B Atkins
1 ,
M T Lotze ,
J P Dutcher ,
R I Fisher ,
G Weiss ,
K Margolin ,
J Abrams ,
M Sznol ,
D Parkinson ,
M Hawkins ,
C Paradise ,
L Kunkel ,
S A Rosenberg
Jul 1999
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the short- and long-term efficacy and toxicity of the high-dose intravenous bolus interleukin 2 (IL-2) regimen in patients with metastatic melanoma.